- call +1-201-465-4211
- email sales@mrinsights.biz
Medical oncologists specialise in cancer treatment using drugs such as chemotherapy agents.
Scope of the Report:
This report focuses on the Oncology/Cancer Drugs in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.
USFDA and European Union have undertaken significant initiatives to fuel the growth of global oncology/cancer drugs market by providing pre-market approval for potential drugs under clinical development.
Asia-Pacific and LAMEA are promising regions for conducting clinical trials due a large population base and the low cost of clinical trials as compared to North America and Europe
Japan has largest share to the total Asia Pacific cancer drug market due to the high prevalence of cancer in Japanese population. Lung cancer is the major cause of death in Japanese population.
The worldwide market for Oncology/Cancer Drugs is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2023, from xx million US$ in 2017, according to a new GIR (Global Info Research) study.
Market Segment by Manufacturers, this report covers
Amgen
Johnson & Johnson
GlaxoSmithKline
Eli lilly
Roche diagnostics
Novartis
Pfizer
Merck
Sanofi
Celgene
Roche
Novartis
Celgene
Market Segment by Regions, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, Colombia etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
Market Segment by Type, covers
Blood Cancer
Breast Cancer
Gastrointestinal Cancer
Prostate Cancer
Respiratory/Lung Cancer
Skin Cancer
Other Cancers
Market Segment by Applications, can be divided into
Hospital
Clinic
Pharmacy
There are 15 Chapters to deeply display the global Oncology/Cancer Drugs market.
Chapter 1, to describe Oncology/Cancer Drugs Introduction, product scope, market overview, market opportunities, market risk, market driving force;
Chapter 2, to analyze the top manufacturers of Oncology/Cancer Drugs, with sales, revenue, and price of Oncology/Cancer Drugs, in 2016 and 2017;
Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;
Chapter 4, to show the global market by regions, with sales, revenue and market share of Oncology/Cancer Drugs, for each region, from 2013 to 2018;
Chapter 5, 6, 7, 8 and 9, to analyze the market by countries, by type, by application and by manufacturers, with sales, revenue and market share by key countries in these regions;
Chapter 10 and 11, to show the market by type and application, with sales market share and growth rate by type, application, from 2013 to 2018;
Chapter 12, Oncology/Cancer Drugs market forecast, by regions, type and application, with sales and revenue, from 2018 to 2023;
Chapter 13, 14 and 15, to describe Oncology/Cancer Drugs sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source
The base year for the study has been considered 2019, historic year 2014 and 2018, the forecast period considered is from 2020 to 2027. The regions analyzed for the market include North America, Europe, South America, Asia Pacific, and Middle East and Africa. These regions are further analyzed at the country-level. The study also includes attractiveness analysis of type, application and regions which are benchmarked based on their market size, growth rate and attractiveness in terms of present and future opportunity for understanding the future growth of the market.
Market is segmented on the basis:
The report offers in-depth analysis of driving factors, opportunities, restraints, and challenges for gaining the key insight of the market. The report emphasizes on all the key trends that play a vital role in the enlargement of the market from 2019 to 2026.
The report provides company profile of the key players operating in the market and a comparative analysis based on their business overviews industry offering, segment market share, regional presence, business strategies, innovations, mergers & acquisitions, recent developments, joint venture, collaborations, partnerships, SWOT analysis, and key financial information.
Table of Contents
1 Market Overview
1.1 Oncology/Cancer Drugs Introduction
1.2 Market Analysis by Type
1.2.1 Blood Cancer
1.2.2 Breast Cancer
1.2.3 Gastrointestinal Cancer
1.2.4 Prostate Cancer
1.2.5 Respiratory/Lung Cancer
1.2.6 Skin Cancer
1.2.7 Other Cancers
1.3 Market Analysis by Applications
1.3.1 Hospital
1.3.2 Clinic
1.3.3 Pharmacy
1.4 Market Analysis by Regions
1.4.1 North America (United States, Canada and Mexico)
1.4.1.1 United States Market States and Outlook (2013-2023)
1.4.1.2 Canada Market States and Outlook (2013-2023)
1.4.1.3 Mexico Market States and Outlook (2013-2023)
1.4.2 Europe (Germany, France, UK, Russia and Italy)
1.4.2.1 Germany Market States and Outlook (2013-2023)
1.4.2.2 France Market States and Outlook (2013-2023)
1.4.2.3 UK Market States and Outlook (2013-2023)
1.4.2.4 Russia Market States and Outlook (2013-2023)
1.4.2.5 Italy Market States and Outlook (2013-2023)
1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.3.1 China Market States and Outlook (2013-2023)
1.4.3.2 Japan Market States and Outlook (2013-2023)
1.4.3.3 Korea Market States and Outlook (2013-2023)
1.4.3.4 India Market States and Outlook (2013-2023)
1.4.3.5 Southeast Asia Market States and Outlook (2013-2023)
1.4.4 South America, Middle East and Africa
1.4.4.1 Brazil Market States and Outlook (2013-2023)
1.4.4.2 Egypt Market States and Outlook (2013-2023)
1.4.4.3 Saudi Arabia Market States and Outlook (2013-2023)
1.4.4.4 South Africa Market States and Outlook (2013-2023)
1.4.4.5 Nigeria Market States and Outlook (2013-2023)
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Amgen
2.1.1 Business Overview
2.1.2 Oncology/Cancer Drugs Type and Applications
2.1.2.1 Product A
2.1.2.2 Product B
2.1.3 Amgen Oncology/Cancer Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.2 Johnson & Johnson
2.2.1 Business Overview
2.2.2 Oncology/Cancer Drugs Type and Applications
2.2.2.1 Product A
2.2.2.2 Product B
2.2.3 Johnson & Johnson Oncology/Cancer Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.3 GlaxoSmithKline
2.3.1 Business Overview
2.3.2 Oncology/Cancer Drugs Type and Applications
2.3.2.1 Product A
2.3.2.2 Product B
2.3.3 GlaxoSmithKline Oncology/Cancer Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.4 Eli lilly
2.4.1 Business Overview
2.4.2 Oncology/Cancer Drugs Type and Applications
2.4.2.1 Product A
2.4.2.2 Product B
2.4.3 Eli lilly Oncology/Cancer Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.5 Roche diagnostics
2.5.1 Business Overview
2.5.2 Oncology/Cancer Drugs Type and Applications
2.5.2.1 Product A
2.5.2.2 Product B
2.5.3 Roche diagnostics Oncology/Cancer Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.6 Novartis
2.6.1 Business Overview
2.6.2 Oncology/Cancer Drugs Type and Applications
2.6.2.1 Product A
2.6.2.2 Product B
2.6.3 Novartis Oncology/Cancer Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.7 Pfizer
2.7.1 Business Overview
2.7.2 Oncology/Cancer Drugs Type and Applications
2.7.2.1 Product A
2.7.2.2 Product B
2.7.3 Pfizer Oncology/Cancer Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.8 Merck
2.8.1 Business Overview
2.8.2 Oncology/Cancer Drugs Type and Applications
2.8.2.1 Product A
2.8.2.2 Product B
2.8.3 Merck Oncology/Cancer Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.9 Sanofi
2.9.1 Business Overview
2.9.2 Oncology/Cancer Drugs Type and Applications
2.9.2.1 Product A
2.9.2.2 Product B
2.9.3 Sanofi Oncology/Cancer Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.10 Celgene
2.10.1 Business Overview
2.10.2 Oncology/Cancer Drugs Type and Applications
2.10.2.1 Product A
2.10.2.2 Product B
2.10.3 Celgene Oncology/Cancer Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.11 Roche
2.11.1 Business Overview
2.11.2 Oncology/Cancer Drugs Type and Applications
2.11.2.1 Product A
2.11.2.2 Product B
2.11.3 Roche Oncology/Cancer Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.12 Novartis
2.12.1 Business Overview
2.12.2 Oncology/Cancer Drugs Type and Applications
2.12.2.1 Product A
2.12.2.2 Product B
2.12.3 Novartis Oncology/Cancer Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
2.13 Celgene
2.13.1 Business Overview
2.13.2 Oncology/Cancer Drugs Type and Applications
2.13.2.1 Product A
2.13.2.2 Product B
2.13.3 Celgene Oncology/Cancer Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)
3 Global Oncology/Cancer Drugs Sales, Revenue, Market Share and Competition by Manufacturer (2016-2017)
3.1 Global Oncology/Cancer Drugs Sales and Market Share by Manufacturer (2016-2017)
3.2 Global Oncology/Cancer Drugs Revenue and Market Share by Manufacturer (2016-2017)
3.3 Market Concentration Rate
3.3.1 Top 3 Oncology/Cancer Drugs Manufacturer Market Share in 2017
3.3.2 Top 6 Oncology/Cancer Drugs Manufacturer Market Share in 2017
3.4 Market Competition Trend
4 Global Oncology/Cancer Drugs Market Analysis by Regions
4.1 Global Oncology/Cancer Drugs Sales, Revenue and Market Share by Regions
4.1.1 Global Oncology/Cancer Drugs Sales and Market Share by Regions (2013-2018)
4.1.2 Global Oncology/Cancer Drugs Revenue and Market Share by Regions (2013-2018)
4.2 North America Oncology/Cancer Drugs Sales and Growth Rate (2013-2018)
4.3 Europe Oncology/Cancer Drugs Sales and Growth Rate (2013-2018)
4.4 Asia-Pacific Oncology/Cancer Drugs Sales and Growth Rate (2013-2018)
4.5 South America Oncology/Cancer Drugs Sales and Growth Rate (2013-2018)
4.6 Middle East and Africa Oncology/Cancer Drugs Sales and Growth Rate (2013-2018)
5 North America Oncology/Cancer Drugs by Countries
5.1 North America Oncology/Cancer Drugs Sales, Revenue and Market Share by Countries
5.1.1 North America Oncology/Cancer Drugs Sales and Market Share by Countries (2013-2018)
5.1.2 North America Oncology/Cancer Drugs Revenue and Market Share by Countries (2013-2018)
5.2 United States Oncology/Cancer Drugs Sales and Growth Rate (2013-2018)
5.3 Canada Oncology/Cancer Drugs Sales and Growth Rate (2013-2018)
5.4 Mexico Oncology/Cancer Drugs Sales and Growth Rate (2013-2018)
6 Europe Oncology/Cancer Drugs by Countries
6.1 Europe Oncology/Cancer Drugs Sales, Revenue and Market Share by Countries
6.1.1 Europe Oncology/Cancer Drugs Sales and Market Share by Countries (2013-2018)
6.1.2 Europe Oncology/Cancer Drugs Revenue and Market Share by Countries (2013-2018)
6.2 Germany Oncology/Cancer Drugs Sales and Growth Rate (2013-2018)
6.3 UK Oncology/Cancer Drugs Sales and Growth Rate (2013-2018)
6.4 France Oncology/Cancer Drugs Sales and Growth Rate (2013-2018)
6.5 Russia Oncology/Cancer Drugs Sales and Growth Rate (2013-2018)
6.6 Italy Oncology/Cancer Drugs Sales and Growth Rate (2013-2018)
7 Asia-Pacific Oncology/Cancer Drugs by Countries
7.1 Asia-Pacific Oncology/Cancer Drugs Sales, Revenue and Market Share by Countries
7.1.1 Asia-Pacific Oncology/Cancer Drugs Sales and Market Share by Countries (2013-2018)
7.1.2 Asia-Pacific Oncology/Cancer Drugs Revenue and Market Share by Countries (2013-2018)
7.2 China Oncology/Cancer Drugs Sales and Growth Rate (2013-2018)
7.3 Japan Oncology/Cancer Drugs Sales and Growth Rate (2013-2018)
7.4 Korea Oncology/Cancer Drugs Sales and Growth Rate (2013-2018)
7.5 India Oncology/Cancer Drugs Sales and Growth Rate (2013-2018)
7.6 Southeast Asia Oncology/Cancer Drugs Sales and Growth Rate (2013-2018)
8 South America Oncology/Cancer Drugs by Countries
8.1 South America Oncology/Cancer Drugs Sales, Revenue and Market Share by Countries
8.1.1 South America Oncology/Cancer Drugs Sales and Market Share by Countries (2013-2018)
8.1.2 South America Oncology/Cancer Drugs Revenue and Market Share by Countries (2013-2018)
8.2 Brazil Oncology/Cancer Drugs Sales and Growth Rate (2013-2018)
8.3 Argentina Oncology/Cancer Drugs Sales and Growth Rate (2013-2018)
8.4 Colombia Oncology/Cancer Drugs Sales and Growth Rate (2013-2018)
9 Middle East and Africa Oncology/Cancer Drugs by Countries
9.1 Middle East and Africa Oncology/Cancer Drugs Sales, Revenue and Market Share by Countries
9.1.1 Middle East and Africa Oncology/Cancer Drugs Sales and Market Share by Countries (2013-2018)
9.1.2 Middle East and Africa Oncology/Cancer Drugs Revenue and Market Share by Countries (2013-2018)
9.2 Saudi Arabia Oncology/Cancer Drugs Sales and Growth Rate (2013-2018)
9.3 UAE Oncology/Cancer Drugs Sales and Growth Rate (2013-2018)
9.4 Egypt Oncology/Cancer Drugs Sales and Growth Rate (2013-2018)
9.5 Nigeria Oncology/Cancer Drugs Sales and Growth Rate (2013-2018)
9.6 South Africa Oncology/Cancer Drugs Sales and Growth Rate (2013-2018)
10 Global Oncology/Cancer Drugs Market Segment by Type
10.1 Global Oncology/Cancer Drugs Sales, Revenue and Market Share by Type (2013-2018)
10.1.1 Global Oncology/Cancer Drugs Sales and Market Share by Type (2013-2018)
10.1.2 Global Oncology/Cancer Drugs Revenue and Market Share by Type (2013-2018)
10.2 Blood Cancer Sales Growth and Price
10.2.1 Global Blood Cancer Sales Growth (2013-2018)
10.2.2 Global Blood Cancer Price (2013-2018)
10.3 Breast Cancer Sales Growth and Price
10.3.1 Global Breast Cancer Sales Growth (2013-2018)
10.3.2 Global Breast Cancer Price (2013-2018)
10.4 Gastrointestinal Cancer Sales Growth and Price
10.4.1 Global Gastrointestinal Cancer Sales Growth (2013-2018)
10.4.2 Global Gastrointestinal Cancer Price (2013-2018)
10.5 Prostate Cancer Sales Growth and Price
10.5.1 Global Prostate Cancer Sales Growth (2013-2018)
10.5.2 Global Prostate Cancer Price (2013-2018)
10.6 Respiratory/Lung Cancer Sales Growth and Price
10.6.1 Global Respiratory/Lung Cancer Sales Growth (2013-2018)
10.6.2 Global Respiratory/Lung Cancer Price (2013-2018)
10.7 Skin Cancer Sales Growth and Price
10.7.1 Global Skin Cancer Sales Growth (2013-2018)
10.7.2 Global Skin Cancer Price (2013-2018)
10.8 Other Cancers Sales Growth and Price
10.8.1 Global Other Cancers Sales Growth (2013-2018)
10.8.2 Global Other Cancers Price (2013-2018)
11 Global Oncology/Cancer Drugs Market Segment by Application
11.1 Global Oncology/Cancer Drugs Sales Market Share by Application (2013-2018)
11.2 Hospital Sales Growth (2013-2018)
11.3 Clinic Sales Growth (2013-2018)
11.4 Pharmacy Sales Growth (2013-2018)
12 Oncology/Cancer Drugs Market Forecast (2018-2023)
12.1 Global Oncology/Cancer Drugs Sales, Revenue and Growth Rate (2018-2023)
12.2 Oncology/Cancer Drugs Market Forecast by Regions (2018-2023)
12.2.1 North America Oncology/Cancer Drugs Market Forecast (2018-2023)
12.2.2 Europe Oncology/Cancer Drugs Market Forecast (2018-2023)
12.2.3 Asia-Pacific Oncology/Cancer Drugs Market Forecast (2018-2023)
12.2.4 South America Oncology/Cancer Drugs Market Forecast (2018-2023)
12.2.5 Middle East and Africa Oncology/Cancer Drugs Market Forecast (2018-2023)
12.3 Oncology/Cancer Drugs Market Forecast by Type (2018-2023)
12.3.1 Global Oncology/Cancer Drugs Sales Forecast by Type (2018-2023)
12.3.2 Global Oncology/Cancer Drugs Market Share Forecast by Type (2018-2023)
12.4 Oncology/Cancer Drugs Market Forecast by Application (2018-2023)
12.4.1 Global Oncology/Cancer Drugs Sales Forecast by Application (2018-2023)
12.4.2 Global Oncology/Cancer Drugs Market Share Forecast by Application (2018-2023)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.1.3 Marketing Channel Future Trend
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
List of Tables and Figures
Figure Oncology/Cancer Drugs Picture
Table Product Specifications of Oncology/Cancer Drugs
Figure Global Sales Market Share of Oncology/Cancer Drugs by Types in 2017
ProactiveWe manage our resources 24/7 to identify issues and address them before they become problems
Quality & ReliabilityWe are committed to providing reliable and highly accurate data with an excellent quality control system
Global Outreach6 Major regions and 40+ countries level analysis accomplished
Competitive PricingOur pricing strategy is highly competitive in the market, without compensating on the quality and the timeline of project delivery
